We believe that the CereMetrixTM BDS will grow and reach statistically relevant scalability to become a leading diagnostic tool related to brain disorders and will eventually become the industry standard in effectively diagnosing brain related illnesses.
Denver, CO (PRWEB) May 29, 2013
CereScan was recently chosen as one of only two companies from Colorado to present at the Health Datapalooza IV, (http://healthdatapalooza.org) an event produced by the Health Data Consortium. The Center for Improving Value in Health Care (CIVHC), (http://www.civhc.org), is part of an effort specifically focused to help support health care innovation in Colorado. CIVHC is serving as a convener of health care organizations, businesses or start-ups with innovative ideas or solutions to integrate health care data into technology that supports better health, better quality of care and lower costs for Coloradans.
The initial selection process concluded with presentations given by numerous companies on March 25th from across the state and judged by a panel comprised of leaders from local technology firms and health data leaders from across Colorado.
The criteria used for selection were as follows:
- The extent to which the application or activity uses health data (did not have to be publicly available data)
- How the application addresses an explicit problem or health issue
- Whether the application is newly created (developed within the past 12 months) or if exhibited during last year’s Datapalooza, features enhanced capabilities
- Whether the application has demonstrated utility (improved health outcomes, reduction in health care costs, etc.)
- Whether the application has a sustainability plan or future plan of use
After a comprehensive selection process conducted in Denver, Colorado, CereScan (http://www.CereScan.com) was one of two companies invited to the 2013 Health Datapalooza IV event. This national forum, with over 1500 attendees, takes place June 3-4, in Washington, DC and will provide CereScan an opportunity to showcase its “Big Data” capabilities targeted at improving brain disorder diagnosis. There will be significant emphasis on demonstrating the power of its patent pending CereMetrixTM Brain Diagnostic System (BDS). This system is believed to be the country’s largest and most complete data warehouse for functional brain imaging and correlated patient clinical histories. CereMetrixTM BDS has been innovatively designed as a data mining tool for medical professionals, research institutions, insurance companies, medical device manufacturers and pharmaceutical companies for a variety of brain disorder applications.
Certain disorders of the brain pose some of the most difficult and vexing challenges to patients, doctors, and insurance providers. Unlike other illnesses of the body that are subject to more straightforward diagnosis, disorders of the brain can often present a variety of symptoms, making an accurate diagnosis of the underlying condition or conditions difficult. As a result, treatment protocols are often less reliable.
CereMetrixTM BDS housed neurological data includes a broad spectrum of conditions, such as mild to moderate traumatic brain injury, Alzheimer’s Disease, various forms of dementia, bipolar disorder, attention deficit hyperactivity disorder (ADHD), anxiety, and autism. The functional imaging patterns uncovered by the CereMetrixTM BDS and expert reading physicians, will allow doctors and researchers to better treat brain ailments as well as expanding the development of new and innovative research opportunities.
John Kelley, Chairman and CEO of CereScan Corp., notes “We believe that the CereMetrixTM BDS will grow and reach statistically relevant scalability to become a leading diagnostic tool related to brain disorders and will eventually become the industry standard in effectively diagnosing brain related illnesses.”
CereScan is positioning itself on the front edge of a wave of adoption by doctors, medical professionals and researchers in multiple disciplines facilitating the value of neuroimaging as a biomarker and developing novel and innovative approaches to the treatment of neurological and psychological disorders.
About CereScan Corp.
As a Denver based neuro-diagnostics company, CereScan combines state-of-the-art SPECT brain imaging technology with a patient centered model of care to provide the highest level of neuro-diagnostics available. Using high definition functional brain imaging, industry leading image reconstruction software, and an extensive library of clinical data, the CereScan medical team provides physicians, researchers, and patients with unmatched objective diagnostic information. CereScan helps patients and their physicians, counselors and families to better understand the biological bases of their conditions and disorders. For more information, please call (866) 722-4806 or visit http://www.CereScan.com
About Health Datapalooza IV
Health Datapalooza IV (HDP IV) is the fourth annual national conference born from government efforts to liberate health data. The conference is a forum that features the newest and most innovative and effective uses of health data by companies, startups, academics, government agencies and individuals. The hallmark of the event is a national competition that searches for the best and most innovative uses of health data in apps and products. The competition culminates in live demonstrations of the winning applications to HDP IV attendees. For more information visit: http://healthdatapalooza.org/